Year-Long diabetes drug trial tests safety in japan
NCT ID NCT02314637
Summary
This study aimed to check the long-term safety and effectiveness of the diabetes drug Teneligliptin (MP-513) over one year. It involved 240 Japanese adults with type 2 diabetes, who took the drug either by itself or alongside another common diabetes medication. Researchers tracked side effects and changes in blood sugar levels to see how well the treatment worked and how safe it was for long-term use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Reserch site
Shikoku, Japan
Conditions
Explore the condition pages connected to this study.